Antimicrobial resistance

Emergence of resistance to many new broad-spectrum agents, as well as to older antimicrobial agents, has again become an alarming problem. Studies reviewed in this paper address methicillin resistance in staphylococci, which can be detected with the mecA gene probe; resistance of enterococci to gent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in infectious diseases 1991-12, Vol.4 (6), p.717-721
1. Verfasser: Barg, Neil
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 721
container_issue 6
container_start_page 717
container_title Current opinion in infectious diseases
container_volume 4
creator Barg, Neil
description Emergence of resistance to many new broad-spectrum agents, as well as to older antimicrobial agents, has again become an alarming problem. Studies reviewed in this paper address methicillin resistance in staphylococci, which can be detected with the mecA gene probe; resistance of enterococci to gentamicin, ampicillin, and glycopeptides; and resistance of other gram-positive cocci such as Pediococcus species, Staphylococcus haemolyticus, and Pneumococcus species to antibiotics. The review also covers the limited use for ciprofloxacin in the treatment of Staphylococcus aureus, salmonellae, and Pseudomonas aeruginosa infections; resistance to third-generation cephalosporins in Klebsiella pneumoniae and Enterobacteriaceae; and imipenem resistance in P. aeruginosa. Finally, studies on the prevalence of antibiotic-resistant organisms in the community and hospital settings are discussed.
doi_str_mv 10.1097/00001432-199112000-00002
format Article
fullrecord <record><control><sourceid>wolterskluwer_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00001432_199112000_00002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00001432-199112000-00002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2472-62bb32a577fa366815520d34a976f9f1f0c2c218f48f83820d34cd47ee1bc2a83</originalsourceid><addsrcrecordid>eNp1kEtLQzEQhYMoeK3uXfYPRDOT97IUX1Bwo-uQmyY0ettKcqX4701bdedshjnDGc43hEyB3QCz-pa1AsGRgrUA2Ca6l_CEdCA0p0qiPiUdsxKo5lqek4ta35oHLVMduZ5txrzOoWz77IdpiTXX0W9CvCRnyQ81Xv30CXm9v3uZP9LF88PTfLagAYVGqrDvOXqpdfJcKQNSIlty4a1WySZILGBAMEmYZLg57MJS6BihD-gNnxBzvNsi1Fpich8lr335csDcntD9Ero_woOEzSqO1t12GGOp78PnLha3in4YV-6_x_BvkK1RNg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Antimicrobial resistance</title><source>Journals@Ovid Complete</source><creator>Barg, Neil</creator><creatorcontrib>Barg, Neil</creatorcontrib><description>Emergence of resistance to many new broad-spectrum agents, as well as to older antimicrobial agents, has again become an alarming problem. Studies reviewed in this paper address methicillin resistance in staphylococci, which can be detected with the mecA gene probe; resistance of enterococci to gentamicin, ampicillin, and glycopeptides; and resistance of other gram-positive cocci such as Pediococcus species, Staphylococcus haemolyticus, and Pneumococcus species to antibiotics. The review also covers the limited use for ciprofloxacin in the treatment of Staphylococcus aureus, salmonellae, and Pseudomonas aeruginosa infections; resistance to third-generation cephalosporins in Klebsiella pneumoniae and Enterobacteriaceae; and imipenem resistance in P. aeruginosa. Finally, studies on the prevalence of antibiotic-resistant organisms in the community and hospital settings are discussed.</description><identifier>ISSN: 0951-7375</identifier><identifier>EISSN: 1473-6527</identifier><identifier>DOI: 10.1097/00001432-199112000-00002</identifier><language>eng</language><publisher>Lippincott-Raven Publishers</publisher><ispartof>Current opinion in infectious diseases, 1991-12, Vol.4 (6), p.717-721</ispartof><rights>Lippincott-Raven Publishers.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Barg, Neil</creatorcontrib><title>Antimicrobial resistance</title><title>Current opinion in infectious diseases</title><description>Emergence of resistance to many new broad-spectrum agents, as well as to older antimicrobial agents, has again become an alarming problem. Studies reviewed in this paper address methicillin resistance in staphylococci, which can be detected with the mecA gene probe; resistance of enterococci to gentamicin, ampicillin, and glycopeptides; and resistance of other gram-positive cocci such as Pediococcus species, Staphylococcus haemolyticus, and Pneumococcus species to antibiotics. The review also covers the limited use for ciprofloxacin in the treatment of Staphylococcus aureus, salmonellae, and Pseudomonas aeruginosa infections; resistance to third-generation cephalosporins in Klebsiella pneumoniae and Enterobacteriaceae; and imipenem resistance in P. aeruginosa. Finally, studies on the prevalence of antibiotic-resistant organisms in the community and hospital settings are discussed.</description><issn>0951-7375</issn><issn>1473-6527</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNp1kEtLQzEQhYMoeK3uXfYPRDOT97IUX1Bwo-uQmyY0ettKcqX4701bdedshjnDGc43hEyB3QCz-pa1AsGRgrUA2Ca6l_CEdCA0p0qiPiUdsxKo5lqek4ta35oHLVMduZ5txrzOoWz77IdpiTXX0W9CvCRnyQ81Xv30CXm9v3uZP9LF88PTfLagAYVGqrDvOXqpdfJcKQNSIlty4a1WySZILGBAMEmYZLg57MJS6BihD-gNnxBzvNsi1Fpich8lr335csDcntD9Ero_woOEzSqO1t12GGOp78PnLha3in4YV-6_x_BvkK1RNg</recordid><startdate>199112</startdate><enddate>199112</enddate><creator>Barg, Neil</creator><general>Lippincott-Raven Publishers</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199112</creationdate><title>Antimicrobial resistance</title><author>Barg, Neil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2472-62bb32a577fa366815520d34a976f9f1f0c2c218f48f83820d34cd47ee1bc2a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barg, Neil</creatorcontrib><collection>CrossRef</collection><jtitle>Current opinion in infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barg, Neil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial resistance</atitle><jtitle>Current opinion in infectious diseases</jtitle><date>1991-12</date><risdate>1991</risdate><volume>4</volume><issue>6</issue><spage>717</spage><epage>721</epage><pages>717-721</pages><issn>0951-7375</issn><eissn>1473-6527</eissn><abstract>Emergence of resistance to many new broad-spectrum agents, as well as to older antimicrobial agents, has again become an alarming problem. Studies reviewed in this paper address methicillin resistance in staphylococci, which can be detected with the mecA gene probe; resistance of enterococci to gentamicin, ampicillin, and glycopeptides; and resistance of other gram-positive cocci such as Pediococcus species, Staphylococcus haemolyticus, and Pneumococcus species to antibiotics. The review also covers the limited use for ciprofloxacin in the treatment of Staphylococcus aureus, salmonellae, and Pseudomonas aeruginosa infections; resistance to third-generation cephalosporins in Klebsiella pneumoniae and Enterobacteriaceae; and imipenem resistance in P. aeruginosa. Finally, studies on the prevalence of antibiotic-resistant organisms in the community and hospital settings are discussed.</abstract><pub>Lippincott-Raven Publishers</pub><doi>10.1097/00001432-199112000-00002</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0951-7375
ispartof Current opinion in infectious diseases, 1991-12, Vol.4 (6), p.717-721
issn 0951-7375
1473-6527
language eng
recordid cdi_crossref_primary_10_1097_00001432_199112000_00002
source Journals@Ovid Complete
title Antimicrobial resistance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T01%3A32%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20resistance&rft.jtitle=Current%20opinion%20in%20infectious%20diseases&rft.au=Barg,%20Neil&rft.date=1991-12&rft.volume=4&rft.issue=6&rft.spage=717&rft.epage=721&rft.pages=717-721&rft.issn=0951-7375&rft.eissn=1473-6527&rft_id=info:doi/10.1097/00001432-199112000-00002&rft_dat=%3Cwolterskluwer_cross%3E00001432-199112000-00002%3C/wolterskluwer_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true